peptide
Melanotan I (afamelanotide) tracker
Educational reference for Melanotan I (afamelanotide). Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
15 h
Tmax
36 h
Category
peptide
Also known as: afamelanotide, scenesse, mt-1, mt1, nle4-d-phe7-alpha-msh
Melanotan I is afamelanotide, an alpha-MSH analogue with one FDA-approved implant product.
Mechanism
A synthetic analogue of alpha-melanocyte-stimulating hormone that acts mainly at the melanocortin-1 receptor.
Research summary
Afamelanotide (Scenesse) is an FDA-approved implant for erythropoietic protoporphyria. Injectable melanotan products sold online are not approved. Melanotan I and melanotan II are different molecules.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- Scenesse (afamelanotide) prescribing information · FDA prescribing informationApparent half-life about 15 h after implant administration, with median Tmax around 36 h. This is an apparent value for a controlled-release implant and may not apply to other formulations.
TrackPep là ứng dụng theo dõi. Ứng dụng chỉ ghi lại những gì bạn nhập, không bao giờ đề xuất hay tính toán lượng dùng.